Literature DB >> 26400378

Declining tuberculosis notification trend associated with strengthened TB and expanded HIV care in Swaziland.

S Haumba1, T Dlamini2, M Calnan1, V Ghazaryan3, A E Smith-Arthur3, P Preko4, P Ehrenkranz5.   

Abstract

This retrospective observational review documents the efforts of the Swaziland National Tuberculosis (TB) Control Programme between 2004 and 2014. The objective is to describe the disparity between actual declines in case notification and increases in estimated incidence. The review of policies and practices shows the most influential factors associated with the decrease in TB case notification to be an increase in access to antiretroviral therapy for co-infected TB patients, the general success of TB and human immunodeficiency virus service integration in the country and improvements in implementation of all components of directly observed treatment, active case finding, and rapid diagnosis using new technologies.

Entities:  

Keywords:  TB case notification; antiretroviral therapy; new and recurrent TB; smear-negative TB

Year:  2015        PMID: 26400378      PMCID: PMC4487488          DOI: 10.5588/pha.15.0008

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  5 in total

1.  Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

Authors:  François-Xavier Blanc; Thim Sok; Didier Laureillard; Laurence Borand; Claire Rekacewicz; Eric Nerrienet; Yoann Madec; Olivier Marcy; Sarin Chan; Narom Prak; Chindamony Kim; Khemarin Kim Lak; Chanroeurn Hak; Bunnet Dim; Chhun Im Sin; Sath Sun; Bertrand Guillard; Borann Sar; Sirenda Vong; Marcelo Fernandez; Lawrence Fox; Jean-François Delfraissy; Anne E Goldfeld
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

2.  The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting.

Authors:  Rein M G J Houben; Judith R Glynn; Sebastian Mboma; Themba Mzemba; Nimrod J Mwaungulu; Lorren Mwaungulu; Michael Mwenibabu; James Mpunga; Neil French; Amelia C Crampin
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

3.  Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis.

Authors:  Adithya Cattamanchi; David W Dowdy; J Lucian Davis; William Worodria; Samuel Yoo; Moses Joloba; John Matovu; Philip C Hopewell; Laurence Huang
Journal:  BMC Infect Dis       Date:  2009-05-06       Impact factor: 3.090

4.  Outcomes and impact of HIV prevention, ART and TB programs in Swaziland--early evidence from public health triangulation.

Authors:  Cari van Schalkwyk; Sibongile Mndzebele; Thabo Hlophe; Jesus Maria Garcia Calleja; Eline L Korenromp; Rand Stoneburner; Cyril Pervilhac
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

5.  Recent patterns in population-based HIV prevalence in Swaziland.

Authors:  George T Bicego; Rejoice Nkambule; Ingrid Peterson; Jason Reed; Deborah Donnell; Henry Ginindza; Yen T Duong; Hetal Patel; Naomi Bock; Neena Philip; Cherry Mao; Jessica Justman
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

  5 in total
  13 in total

1.  High mortality in tuberculosis patients despite HIV interventions in Swaziland.

Authors:  G Mchunu; J van Griensven; S G Hinderaker; W Kizito; W Sikhondze; M Manzi; T Dlamini; A D Harries
Journal:  Public Health Action       Date:  2016-06-21

2.  Scale-up of ART in Malawi has reduced case notification rates in HIV-positive and HIV-negative tuberculosis.

Authors:  H Kanyerere; B Girma; J Mpunga; K Tayler-Smith; A D Harries; A Jahn; F M Chimbwandira
Journal:  Public Health Action       Date:  2016-12-21

3.  Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe.

Authors:  K C Takarinda; A D Harries; C Sandy; T Mutasa-Apollo; C Zishiri
Journal:  Public Health Action       Date:  2016-09-21

4.  TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings.

Authors:  I Pathmanathan; S Ahmedov; E Pevzner; G Anyalechi; S Modi; H Kirking; J S Cavanaugh
Journal:  Int J Tuberc Lung Dis       Date:  2018-06-01       Impact factor: 2.373

5.  Perceived risk of tuberculosis infection among healthcare workers in Swaziland.

Authors:  Yi-Hao Weng; Patience Thulile Bhembe; Hung-Yi Chiou; Chun-Yuh Yang; Ya-Wen Chiu
Journal:  BMC Infect Dis       Date:  2016-11-23       Impact factor: 3.090

6.  BUTIMBA: Intensifying the Hunt for Child TB in Swaziland through Household Contact Tracing.

Authors:  Anna Maria Mandalakas; Katherine Ngo; Pilar Alonso Ustero; Rachel Golin; Florence Anabwani; Bulisile Mzileni; Welile Sikhondze; Robert Stevens
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

7.  The rise and fall of tuberculosis in Malawi: associations with HIV infection and antiretroviral therapy.

Authors:  Henry Kanyerere; Anthony D Harries; Katie Tayler-Smith; Andreas Jahn; Rony Zachariah; Frank M Chimbwandira; James Mpunga
Journal:  Trop Med Int Health       Date:  2015-11-16       Impact factor: 2.622

8.  Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study.

Authors:  Yolanda Mueller; Qhubekani Mpala; Bernhard Kerschberger; Barbara Rusch; Gugu Mchunu; Sikhathele Mazibuko; Maryline Bonnet
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

9.  High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.

Authors:  Ishani Pathmanathan; Munyaradzi Pasipamire; Sherri Pals; E Kainne Dokubo; Peter Preko; Trong Ao; Sikhathele Mazibuko; Janet Ongole; Themba Dhlamini; Samson Haumba
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

Review 10.  What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?

Authors:  Anthony D Harries; Yan Lin; Ajay M V Kumar; Srinath Satyanarayana; Kudakwashe C Takarinda; Riitta A Dlodlo; Rony Zachariah; Piero Olliaro
Journal:  F1000Res       Date:  2018-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.